Global Blood Therapeutics, Inc. (GBT), is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. More »

Recent News

11/07/19GBT Reports Recent Business Progress and Third Quarter 2019 Financial Results
11/06/19GBT Announces Upcoming Data Presentations at 61st American Society of Hematology Annual Meeting & Exposition
11/04/19GBT Announces New Employment Inducement Grants
10/21/19GBT Announces Results of Post-hoc Analysis of Phase 3 HOPE Study Showing Improvement in Leg Ulcers in Patients with Sickle Cell Disease Treated with Voxelotor

More »

Media Resources

Media Contact

Stephanie Yao